Safety, Resource Use, and Quality of Life in Paramount: A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer-Reference-Cited by-同舟云学术

Safety, Resource Use, and Quality of Life in Paramount: A Phase III Study of Maintenance Pemetrexed Versus Placebo after Induction Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer

Published:2012-11 Issue:11 Volume:7 Page:1713-1721
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Gridelli Cesare,de Marinis Filippo,Pujol Jean-Louis,Reck Martin,Ramlau Rodryg,Parente Barbara,Pieters Thierry,Middleton Gary,Corral Jesus,Winfree Katherine,Melemed Symantha,Zimmermann Anna,John William,Beyrer Julie,Chouaki Nadia,Visseren-Grul Carla,Paz-Ares Luis G.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference24 articles.

1. 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer;Azzoli;J Clin Oncol,2011

2. Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer;Fidias;J Clin Oncol,2009

3. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study;Ciuleanu;Lancet,2009

4. Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study;Cappuzzo;Lancet Oncol,2010

5. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews;Silvestri;BMJ,1998

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Utility Analysis of Maintenance Pemetrexed Plus Best Supportive Care Compared With Best Supportive Care Alone in Treating Patients With Non–Small Cell Lung Cancer in Jordan;Value in Health Regional Issues;2024-09

2. Systemic therapy and radiotherapy related complications and subsequent hospitalisation rates: a systematic review;BMC Cancer;2024-07-10

3. The FJQR Has Synergistic Effect with Fluoropyrimidine in the Maintenance Treatment for HER-2 Negative Gastric Cancer;Recent Patents on Anti-Cancer Drug Discovery;2024-05

4. Renal function-based versus standard dosing of pemetrexed: a randomized controlled trial;Cancer Chemotherapy and Pharmacology;2022-11-21

5. Maintenance treatment in advanced HER2-negative gastric cancer;Clinical and Translational Oncology;2020-06-19